Cargando…
Nullscript inhibits Cryptosporidium and Toxoplasma growth
Cryptosporidium and Toxoplasma are parasites that have caused problems worldwide. Cryptosporidium causes severe watery diarrhoea and may be fatal in immunocompromised patients and in infants. Nitazoxanide is the only agent currently approved by the FDA, but its efficacy is limited. Toxoplasmosis is...
Autores principales: | Murakoshi, Fumi, Bando, Hironori, Sugi, Tatsuki, Adeyemi, Oluyomi Stephen, Nonaka, Motohiro, Nakaya, Takaaki, Kato, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593347/ https://www.ncbi.nlm.nih.gov/pubmed/33120250 http://dx.doi.org/10.1016/j.ijpddr.2020.10.004 |
Ejemplares similares
-
Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2017) -
Modulation of host HIF-1α activity and the tryptophan pathway contributes to the anti-Toxoplasma gondii potential of nanoparticles
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2017) -
Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion
por: Inomata, Atsuko, et al.
Publicado: (2015) -
The role of atypical MAP kinase 4 in the host interaction with Cryptosporidium parvum
por: Watanabe, Nina, et al.
Publicado: (2023) -
Molecular identification of Cryptosporidium isolates from ill exotic pet animals in Japan including a new subtype in Cryptosporidium fayeri
por: Takaki, Youki, et al.
Publicado: (2020)